Oncology
Hodgkin's Disease
0
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Hodgkin's Disease is an early-stage landscape with 0 programs across 1 company. The most active players are Sanofi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
24
clinical trials
Completed18 · 75%
Unknown status3 · 13%
Active, not recruiting1 · 4%
Withdrawn1 · 4%
Terminated1 · 4%
Clinical Trials
Trial Activity
24 trials
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
Active, not recruiting·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 3·NCT00002462·615 enrolled
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00000626·27 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)